Stay updated on Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now displayed, replacing the previous v3.3.3. No study data, eligibility criteria, or key content appears to be altered.
    Difference
    0.1%
    Check dated 2026-01-14T03:53:50.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    A centralized 'Locations' section was added, listing Massachusetts and New York sites, consolidating the previous state-specific location headings. The separate 'Massachusetts Locations' and 'New York Locations' subsections were removed, and the HHS Vulnerability Disclosure link was deleted.
    Difference
    0.3%
    Check dated 2025-12-23T21:07:08.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Publications are now described as automatically filled from PubMed and may not all pertain to the study, and the page revision has been updated to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:56:50.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The banner about government funding status and operating status has been removed from the page.
    Difference
    0.4%
    Check dated 2025-11-18T06:59:22.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    No significant additions or deletions were detected; the Study Details page content appears unchanged, including eligibility criteria and locations.
    Difference
    0.4%
    Check dated 2025-11-03T21:00:23.000Z thumbnail image
  8. Check
    104 days ago
    Change Detected
    Summary
    Update includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.
    Difference
    3%
    Check dated 2025-10-06T05:23:20.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.